These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 22726382)

  • 41. [Chronic hepatitis B: current therapy].
    Buffet C
    Bull Acad Natl Med; 2008 Nov; 192(8):1625-37; discussion 1638-9. PubMed ID: 19445377
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding.
    Giles M; Visvanathan K; Sasadeusz J
    Antivir Ther; 2011; 16(5):621-8. PubMed ID: 21817183
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment with interferons (including pegylated interferons) in patients with hepatitis B.
    Cooksley WG
    Semin Liver Dis; 2004; 24 Suppl 1():45-53. PubMed ID: 15192801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis B and liver transplantation: 2008 update.
    Beckebaum S; Sotiropoulos GC; Gerken G; Cicinnati VR
    Rev Med Virol; 2009 Jan; 19(1):7-29. PubMed ID: 18816503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues.
    Lampertico P; Colombo M
    Liver Int; 2009 Jan; 29 Suppl 1():130-2. PubMed ID: 19207976
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimal therapy of chronic hepatitis B: how do I treat HBeAg-positive patients?
    Vlachogiannakos J; Papatheodoridis GV
    Liver Int; 2015 Jan; 35 Suppl 1():100-6. PubMed ID: 25529094
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic hepatitis B: peginterferon or nucleos(t)ide analogues?
    Sonneveld MJ; Janssen HL
    Liver Int; 2011 Jan; 31 Suppl 1():78-84. PubMed ID: 21205142
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacotherapy of hepatitis B infection: a brief review.
    Quan DJ
    Nephrol Nurs J; 2008; 35(5):507-10, 534. PubMed ID: 18856082
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon?
    Kao JH
    Liver Int; 2014 Feb; 34 Suppl 1():112-9. PubMed ID: 24373087
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Avoiding and managing lamivudine resistance in chronic hepatitis B: current approaches and potential strategies including pegylated interferon.
    Marcellin P; Sung J; Piratvisuth T
    Liver Int; 2010 May; 30(5):657-68. PubMed ID: 20158610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. On-treatment monitoring of chronic hepatitis B virus infection: an Asian-Pacific perspective.
    Chien RN
    J Gastroenterol Hepatol; 2010 May; 25(5):852-7. PubMed ID: 20546437
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Management of chronic hepatitis B in treatment-naive patients].
    Cheong JY
    Korean J Gastroenterol; 2008 Jun; 51(6):338-45. PubMed ID: 18604135
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [New approaches in the treatment of hepatitis B].
    Sagir A; Avci A; Erhardt A; Lörke J; Heintges T; Häussinger D
    Dtsch Med Wochenschr; 2004 May; 129(21):1203-8. PubMed ID: 15160325
    [No Abstract]   [Full Text] [Related]  

  • 54. [Pharmacological treatment of acute hepatitis B].
    García-Alonso FJ; Martín-Mateos RM; Moreira Vicente V
    Med Clin (Barc); 2012 May; 138(14):633-7. PubMed ID: 22118973
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current treatment guidelines of chronic hepatitis B: The role of nucleos(t)ide analogues and peginterferon.
    Ghany MG
    Best Pract Res Clin Gastroenterol; 2017 Jun; 31(3):299-309. PubMed ID: 28774412
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current practice of chronic hepatitis B treatment in Southern Italy.
    Stroffolini T; Spadaro A; Di Marco V; Scifo G; Russello M; Montalto G; Bertino G; Surace L; Caroleo B; Foti G; Portelli V; Madonia S; Sapienza M; Cosco L; Frugiuele P; Galdieri A; Brandolino N; Siciliano R; Bruno S; Almasio PL;
    Eur J Intern Med; 2012 Jul; 23(5):e124-7. PubMed ID: 22726382
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues.
    Buster EH; Schalm SW; Janssen HL
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1093-108. PubMed ID: 19187869
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Pharmacological agents for the treatment of chronic hepatitis B].
    Sánchez-Tapias JM
    Gastroenterol Hepatol; 2008 Mar; 31(3):120-8. PubMed ID: 18341843
    [No Abstract]   [Full Text] [Related]  

  • 59. Optimal therapy of chronic hepatitis B: how do I treat my HBeAg-negative patients?
    Viganò M; Invernizzi F; Lampertico P
    Liver Int; 2015 Jan; 35 Suppl 1():107-13. PubMed ID: 25529095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HBeAg-positive chronic hepatitis B: why do i treat my patients with Nucleos(t)ide analogs?
    Buti M
    Liver Int; 2014 Feb; 34 Suppl 1():108-11. PubMed ID: 24373086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 3.